Back
The Goldman Sachs Group Vs. Kymera Therapeutics Industry Stock Comparison
Buy
63
GS
The Goldman Sachs Group
Last Price:
517.92
Seasonality Move:
6.08%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
46.17
Seasonality Move:
69.6%
Buy
63
The Goldman Sachs Group (GS)
is a Buy
Is The Goldman Sachs Group a Buy, Sell or Hold?
- The current The Goldman Sachs Group [GS] share price is $524.40. The Score for GS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- GS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $47.65. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GS Stock Price Chart
What is The Goldman Sachs Group's stock price today?
-
The The Goldman Sachs Group share price today is $524.40
The current trend is moderately bullish and GS is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $47.65
The current trend is moderately bearish and KYMR is experiencing slight selling pressure.
GS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.44 | Buy |
| Relative Strength Index (14 RSI): | 59.62 | Buy |
| Chaikin Money Flow: | -813820 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (495.06 - 523.16) | Buy |
| Bollinger Bands (100): | (466.64 - 510.02) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.6 | Buy |
| Relative Strength Index (14 RSI): | 52.44 | Buy |
| Chaikin Money Flow: | -88534 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.05 - 49.09) | Buy |
| Bollinger Bands (100): | (36.61 - 48.91) | Buy |
GS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 520.33 | Buy |
| 20-day SMA: | 512.79 | Buy |
| 50-day SMA: | 500.92 | Buy |
| 200-day SMA: | 449.57 | Buy |
| 8-day EMA: | 521.13 | Buy |
| 20-day EMA: | 514.41 | Buy |
| 50-day EMA: | 502.85 | Buy |
| 200-day EMA: | 455.15 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.2 | Sell |
| 20-day SMA: | 46.01 | Buy |
| 50-day SMA: | 47.06 | Buy |
| 200-day SMA: | 39.57 | Buy |
| 8-day EMA: | 47.93 | Sell |
| 20-day EMA: | 47.19 | Buy |
| 50-day EMA: | 46.06 | Buy |
| 200-day EMA: | 39.32 | Buy |
The Goldman Sachs Group Earnings Growth & GS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.94 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.11 per share, and an increase next year of $4.98 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
The Goldman Sachs Group Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||